CS
SYNH

Comerica Securities’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Comerica Securities’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-881
Closed -$32.3K – 1487
2022
Q4 		$32.3K Buy
+881
New +$34.8K ﹤0.01% 818
2022
Q1 		– Sell
-2,068
Closed -$212K – 537
2021
Q4 		$212K Buy
+2,068
New +$199K 0.01% 482

Other funds holding SYNH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Comerica Securities's SYNH Position: Q1 2023 in Review

Comerica Securities sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 881 shares — an estimated $32.3K sold.

Comerica Securities first reported a position in SYNH in Q4 2021 and held it in 2 quarters. The position peaked at $212K in Q4 2021. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

  • Comerica Securities reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Comerica Securities sold 881 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $32.3K.
  • Comerica Securities first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 2 quarters.
  • Comerica Securities's Syneos Health, Inc. Class A Common Stock position peaked at $212K in Q4 2021.
  • 305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.